521 related articles for article (PubMed ID: 27301475)
1. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
[TBL] [Abstract][Full Text] [Related]
2. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
[TBL] [Abstract][Full Text] [Related]
3. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
[TBL] [Abstract][Full Text] [Related]
4. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
[TBL] [Abstract][Full Text] [Related]
5. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
[TBL] [Abstract][Full Text] [Related]
6. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
[TBL] [Abstract][Full Text] [Related]
7. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
[TBL] [Abstract][Full Text] [Related]
10. Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.
Seidel T; Navankasattusas S; Ahmad A; Diakos NA; Xu WD; Tristani-Firouzi M; Bonios MJ; Taleb I; Li DY; Selzman CH; Drakos SG; Sachse FB
Circulation; 2017 Apr; 135(17):1632-1645. PubMed ID: 28073805
[TBL] [Abstract][Full Text] [Related]
11. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
[TBL] [Abstract][Full Text] [Related]
12. One-Year Clinical Outcome in End-Stage Heart Failure: Comparison of "High Urgent" Listing for Heart Transplantation with Mechanical Circulatory Support Implantation.
Sunavsky J; Zittermann A; Oezpeker C; Fujita B; Fuchs U; Gummert JF; Schulz U
Thorac Cardiovasc Surg; 2015 Dec; 63(8):647-52. PubMed ID: 26177226
[TBL] [Abstract][Full Text] [Related]
13. Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device.
Tseng CCS; Huibers MMH; Gaykema LH; Siera-de Koning E; Ramjankhan FZ; Maisel AS; de Jonge N
Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29325227
[TBL] [Abstract][Full Text] [Related]
14. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
[TBL] [Abstract][Full Text] [Related]
15. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.
Ahmad T; Wang T; O'Brien EC; Samsky MD; Pura JA; Lokhnygina Y; Rogers JG; Hernandez AF; Craig D; Bowles DE; Milano CA; Shah SH; Januzzi JL; Felker GM; Patel CB
JACC Heart Fail; 2015 Jan; 3(1):30-39. PubMed ID: 25447345
[TBL] [Abstract][Full Text] [Related]
16. Reduced Myocardial Mitochondrial ROS Production in Mechanically Unloaded Hearts.
Scheiber D; Zweck E; Jelenik T; Horn P; Albermann S; Masyuk M; Boeken U; Saeed D; Kelm M; Roden M; Szendroedi J; Westenfeld R
J Cardiovasc Transl Res; 2019 Apr; 12(2):107-115. PubMed ID: 29589269
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.
Nair PK; Kormos RL; Teuteberg JJ; Mathier MA; Bermudez CA; Toyoda Y; Dew MA; Simon MA
J Heart Lung Transplant; 2010 Feb; 29(2):201-8. PubMed ID: 20113910
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.
Catino AB; Ferrin P; Wever-Pinzon J; Horne BD; Wever-Pinzon O; Kfoury AG; McCreath L; Diakos NA; McKellar S; Koliopoulou A; Bonios MJ; Al-Sarie M; Taleb I; Dranow E; Fang JC; Drakos SG
Eur J Heart Fail; 2018 Jan; 20(1):164-174. PubMed ID: 29094485
[TBL] [Abstract][Full Text] [Related]
19. Rescuing Patients With Severe Biventricular Failure in the Era of Continuous-Flow Left Ventricular Assist Device.
Saito S; Toda K; Nakamura T; Miyagawa S; Yoshikawa Y; Hata H; Yoshioka D; Kainuma S; Yoshida S; Sawa Y
Circ J; 2019 Jan; 83(2):379-385. PubMed ID: 30531119
[TBL] [Abstract][Full Text] [Related]
20. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
